In the NSCLC dataset, the median survival duration for the TACC3 low-expression group was not achieved owing to the limited number of deaths, whereas it was 68.03 months for the TACC3 high-expression group (P = 0.024). The gene discussed is TACC3; the disease is non-small cell lung carcinoma.